Network with the CEOs and directors of Xtract Resources and Oxford Pharmascience in London on 25th May
The SHARES Investor Evenings are designed to showcase a number of presentations from dynamic companies to discuss their latest plans regarding development and growth.
This gives you the opportunity to meet and ask questions directly to the leaders of the companies presenting.
Date: 25th May 2016, Location: Novotel Tower Bridge, 10 Pepys Street, London, EC3N 2NR, Registration: 18:00, Presentations: 18:30, Followed by drinks and canapés
Marcelo Bravo, CEO and Chris Hill, CFO – Oxford Pharmascience (OXP)
Oxford Pharmascience is a drug development company that re-develops approved drugs using proprietary formulation technologies to make them better, safer and easier to take. Since the company’s products incorporate previously approved drugs, this reduces risk and results in a simplified drug development regulatory pathway allowing less expensive development programs and faster access to market. The Company’s pipeline is focused on pain relief and cardiovascular disease indications addressing unmet patient needs with significant commercial potential in global markets.
Jan Nelson, CEO – Xtract Resources (XTR)
Xtract Resources is a gold mining and development company with projects in Mozambique and South America. Its strategic focus is on developing low cost projects with a significant growth profile and a target to produce c100,000oz gold by 2018. This target is achievable following the completion of the acquisition of the Manica gold project in Mozambique, in March 2016 combined with gold production from its Chepica Mine in Chile.
Further Companies Will be Announced Shortly – Book My Complimentary Ticket